2010ESMO宮頸癌臨床實踐指南
《2010ESMO宮頸癌臨床實踐指南》內容簡介：
The crude incidence of cervical cancer in the European Unionis 13.2/100 000 and the crude mortality rate is 5.9/100 000women/year. Nearly 500 000 cervical cancer new cases areoccurring worldwide each year, responsible for 274 000 deaths.
《2010ESMO宮頸癌臨床實踐指南》內容預覽：
Cervical cancer represents the third most common cause offemale mortality. The mortality is 10 times higher in developingcountries, where 80% of new cases occur, compared withdeveloped countries, since screening and treatmentprogrammes are frequently inaccessible to women indeveloping countries.
The screening capacity is satisfactory inmost European Union member states, even if, based on datafrom available screening registers, the coverage of the screeningtest is <80% in all programmes, ranging from 10% to 79%.Early age at first sexual intercourse and early pregnancies havebeen recently evidenced as risk factors for cervical cancer indeveloping countries. High-risk persistent infection withsexually transmittable human papillomavirus is responsible forvirtually all cases of cervical cancer. HPV-16 and HPV-18 arethe most prevalent of the oncogenic types. In addition toscreening techniques including conventional Papanicolaousmear and HPV DNA testing, primary prevention viavaccination against HPV is now available.
點擊下載***：《2010ESMO宮頸癌臨床實踐指南》
本站所注明來源為"愛愛醫(yī)"的文章，版權歸作者與本站共同所有，非經授權不得轉載。
本站所有轉載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進行刪除處理
- 相關閱讀
- ·宮頸癌的早期診斷方法
- ·子宮頸癌的治療
- ·子宮頸癌轉移途徑
- ·子宮頸癌癥狀
- ·p16/Ki-67雙染檢測 助力宮頸癌前病變診斷
熱點圖文
-
2013我國胰腺囊性腫瘤共識意見草案
本共識意見（草案）依據(jù)我國胰腺囊性腫瘤的最近研究，并參考國際相關指南和研究...[詳細]
-
2013NCCN結直腸癌指南
在美國，結直腸癌發(fā)病率占所有癌癥的第四位，而死亡率為第二位。2012年估計...[詳細]
